BACKGROUND: Babesiosis is an emerging tick-borne infection in humans. The increasing numbers of reported cases of transfusion-associated babesiosis (TAB), primarily caused by Babesia microti, represents a concern for the safety of the US blood supply. STUDY DESIGN AND METHODS: This study investigated kinetics of parasitemia and innate immune responses and dynamics of antibody responses during B. microti infection in rhesus macaques (RMs) using blood smears, quantitative polymerase chain reaction (qPCR), flow cytometry, and indirect fluorescent antibody testing. A total of six monkeys were transfused with either hamster or monkey-passaged B. microti-infected red blood cells (two and four monkeys, respectively) simulating TAB. RESULTS: The prepatent period in monkeys inoculated with hamster-passaged B. microti was 35 days compared with 4 days in monkeys transfused with monkey-passaged B. microti; the latter monkeys also had markedly higher parasitemia levels. The duration of the window period from the first detected parasitemia by qPCR analysis to the first detected antibody response ranged from 10 to 17 days. Antibody responses fluctuated during the course of the infection. Innate responses assessed by the frequencies of monocytes and activated B cells correlated with the kinetics and magnitude of parasitemia. On Day 14, additional activation peaks were noted for CD14+CD16+ and CD14-CD16+ monocytes and for CD11c+ myeloid dendritic cells, but only in animals transfused with monkey-passaged B. microti. Parasitemia persisted in these immunocompetent animals, similar to human infection. CONCLUSION: The results suggest that transfusion-associated transmission of B. microti leads to rapid onset of parasitemia (Day 4) in RMs, detectable antibody response 14 days later, and persistent parasitemia.
BACKGROUND:Babesiosis is an emerging tick-borne infection in humans. The increasing numbers of reported cases of transfusion-associated babesiosis (TAB), primarily caused by Babesia microti, represents a concern for the safety of the US blood supply. STUDY DESIGN AND METHODS: This study investigated kinetics of parasitemia and innate immune responses and dynamics of antibody responses during B. microti infection in rhesus macaques (RMs) using blood smears, quantitative polymerase chain reaction (qPCR), flow cytometry, and indirect fluorescent antibody testing. A total of six monkeys were transfused with either hamster or monkey-passaged B. microti-infected red blood cells (two and four monkeys, respectively) simulating TAB. RESULTS: The prepatent period in monkeys inoculated with hamster-passaged B. microti was 35 days compared with 4 days in monkeys transfused with monkey-passaged B. microti; the latter monkeys also had markedly higher parasitemia levels. The duration of the window period from the first detected parasitemia by qPCR analysis to the first detected antibody response ranged from 10 to 17 days. Antibody responses fluctuated during the course of the infection. Innate responses assessed by the frequencies of monocytes and activated B cells correlated with the kinetics and magnitude of parasitemia. On Day 14, additional activation peaks were noted for CD14+CD16+ and CD14-CD16+ monocytes and for CD11c+ myeloid dendritic cells, but only in animals transfused with monkey-passaged B. microti. Parasitemia persisted in these immunocompetent animals, similar to humaninfection. CONCLUSION: The results suggest that transfusion-associated transmission of B. microti leads to rapid onset of parasitemia (Day 4) in RMs, detectable antibody response 14 days later, and persistent parasitemia.
Authors: M J Homer; E S Bruinsma; M J Lodes; M H Moro; S Telford; P J Krause; L D Reynolds; R Mohamath; D R Benson; R L Houghton; S G Reed; D H Persing Journal: J Clin Microbiol Date: 2000-01 Impact factor: 5.948
Authors: Evan M Bloch; Tzong-Hae Lee; Peter J Krause; Sam R Telford; Lani Montalvo; Daniel Chafets; Sahar Usmani-Brown; Timothy J Lepore; Michael P Busch Journal: Transfusion Date: 2013-01-30 Impact factor: 3.157
Authors: Leonie M van Duivenvoorde; Annemarie Voorberg-van der Wel; Nicole M van der Werff; Gerco Braskamp; Edmond J Remarque; Ivanela Kondova; Clemens H M Kocken; Alan W Thomas Journal: Infect Immun Date: 2010-01-04 Impact factor: 3.441
Authors: Andrew E Levin; Phillip C Williamson; James L Erwin; Sherri Cyrus; Evan M Bloch; Beth H Shaz; Debra Kessler; Sam R Telford; Peter J Krause; Gary P Wormser; Xiaoyan Ni; Haihong Wang; Neil X Krueger; Sally Caglioti; Michael P Busch Journal: Transfusion Date: 2014-07-04 Impact factor: 3.157
Authors: Yong Wang; TaLesa Aderohunmu; Henry Bishop; Isabel McAuliffe; Hilda N Rivera; Darlyne Smith; Patricia P Wilkins; Katherine E Bowden; Matthew S Reed; Pavel Svoboda; Olga Stuchlik; Jan Pohl; Ryan E Wiegand; Sukwan Handali Journal: J Clin Microbiol Date: 2021-08-25 Impact factor: 5.948
Authors: Kevin Cheng; Kelly E Coller; Christopher C Marohnic; Zachary A Pfeiffer; James R Fino; Randee R Elsing; Janet Bergsma; Marilee A Marcinkus; Alak K Kar; Orlando H Gumbs; Kathy S Otis; Jeffrey Fishpaugh; Phillip W Schultz; Mark R Pope; Alfredo R Narvaez; Susan J Wong; Susan Madison-Antenucci; Thomas P Leary; George J Dawson Journal: J Clin Microbiol Date: 2018-07-26 Impact factor: 5.948
Authors: Kaitlin M Young; Tricia Corrin; Barbara Wilhelm; Carl Uhland; Judy Greig; Mariola Mascarenhas; Lisa A Waddell Journal: PLoS One Date: 2019-12-30 Impact factor: 3.240